Revista Salud Bosque · Jul 26, 2026
Recommendations Regarding Statin Therapy in Adults Over 70 Years
By León JL, Avella N, Castellanos A et al.
Introduction. Statins are essential for cardiovascular prevention, but their use in individuals over 75 is debated due to potential adverse effects, limited trial data, and guidelines primarily support their use up to said age. With an aging population and a rising burden of cardiovascular disease, optimizing lipid-lowering strategies in older adults is increasingly important. Objective. To review the current evidence on the risks and benefits of statin therapy in adults over 70 years of age. Methods. A search was conducted in PubMed, Embase, Scopus, and Google Scholar, including articles published between January 2020 and February 2025, with no language restrictions. Observational studies, clinical trials, systematic reviews, and case reports on statin use in individuals over 70 years old were analyzed. Two independent reviewers selected the articles, with a third resolving discrepancies. Results. This review included 18 studies (1,015,142 participants), with varying designs and geographic representation. Atorvastatin and rosuvastatin were the most commonly used statins. Myalgias were the most frequent adverse event (38.89%), followed by rare severe liver disease, sarcopenia, and new-onset diabetes (5.56% each). Ten studies (55.56%) supported statin use, emphasizing cardiovascular benefits. Conclusion. This review supports the use of statins in older adults for primary cardiovascular prevention, while emphasizing the need for individualized risk-benefit assessment. Statin prescriptions should be tailored to age and comorbidities to optimize safety and efficacy.